Literature DB >> 6087873

Neutral proteinases and other neutrophil enzymes in psoriasis, and their relation to disease activity.

W Gliński, D Barszcz, E Janczura, Z Zarebska, S Jabłońska.   

Abstract

The activities of elastase, cathepsin G, lysozyme and myeloperoxidase of polymorphonuclear leukocytes were determined by spectrophotometry in thirty-six patients with psoriatic lesions, twelve symptom-free patients with psoriasis and fifteen normal controls. The mean activities of cathepsin G, elastase and lysozyme were found to be increased by 55 to 70% in patients with actively spreading plaque lesions compared with healthy controls (P less than 0.01). Most patients with guttate lesions had total enzyme activities within the normal range. Those with stationary plaque psoriasis had activities of both neutral proteinases (cathepsin G and elastase) which were about 40% lower than normal controls (P less than 0.05). In the lesion-free psoriatics, the activities of neutral proteinases were about 70% of control values. Our findings emphasize the importance of assessment of disease activity in this sort of investigation. The present data may help to resolve much of the confusion regarding PMN function in psoriasis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6087873     DOI: 10.1111/j.1365-2133.1984.tb04037.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  10 in total

1.  Myeloperoxidase of polymorphonuclear leukocytes in psoriasis vulgaris.

Authors:  H Greiten; M Rister; G K Steigleder
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

2.  Leukopheresis for treatment of psoriasis: is therapeutical benefit related to reduced activities of neutral proteinases of polymorphonuclear leukocytes?

Authors:  W Gliński; D Barszcz; S Jabłońska; Z Zarebska; M Tigałonowa; E Janczura
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

3.  Alpha 1-proteinase inhibitor in psoriasis: reduced activity in symptom-free patients and during flare.

Authors:  D Barszcz; Z Zarebska; M Glińska-Ferenz; S Jabłońska; M Tigałonowa; W Gliński
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

4.  Excessive costimulation of CD3-dependent lymphocyte response by extracellular matrix proteins in severe widespread psoriasis.

Authors:  W Glinski; A Gorski; M Glinska-Ferenz; S Majewski; B Stepien-Sopniewska
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

5.  Decreased expression levels of L-selectin on subsets of leucocytes and increased serum L-selectin in severe psoriasis.

Authors:  M Inaoki; S Sato; Y Shimada; S Kawara; D A Steeber; T F Tedder; K Takehara
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

6.  Basement membrane zone as a target for human neutrophil elastase in psoriasis.

Authors:  W Glinski; M Jarzabek-Chorzelska; M Kuligowski; M Pierozynska-Dubowska; M Glinska-Ferenz; S Jabłonska
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

7.  Decreased specific anti-elastase activity in the uninvolved skin of patients with psoriasis.

Authors:  W Glinski; M Pierozynska-Dubowska; M Glinska-Ferenz; S Jablońska
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

8.  Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways.

Authors:  K E Nograles; L C Zaba; E Guttman-Yassky; J Fuentes-Duculan; M Suárez-Fariñas; I Cardinale; A Khatcherian; J Gonzalez; K C Pierson; T R White; C Pensabene; I Coats; I Novitskaya; M A Lowes; J G Krueger
Journal:  Br J Dermatol       Date:  2008-08-05       Impact factor: 9.302

Review 9.  The role of IL-17 in vitiligo: A review.

Authors:  Rasnik K Singh; Kristina M Lee; Ivan Vujkovic-Cvijin; Derya Ucmak; Benjamin Farahnik; Michael Abrouk; Mio Nakamura; Tian Hao Zhu; Tina Bhutani; Maria Wei; Wilson Liao
Journal:  Autoimmun Rev       Date:  2016-01-21       Impact factor: 9.754

10.  Etretinate or cyclosporin-A treatment normalizes the enhanced respiratory burst of polymorphonuclear leukocytes in psoriasis.

Authors:  R E Schopf; J Höcher; M Rehder; L Färber; B Morsches
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.